(Former) HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Opioids and Controlled Substances
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDA
|
2009
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating Medicines Partnership
|
Other
|
FDA
|
NIA, NIAMS, NIDDK, NINDS, OD/ OSP
|
2014
|
|
AccessGUDID
|
Resource Development
|
FDA
|
NLM
|
2015
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NIAID
|
2013
|
|
Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA
|
NIDDK, NIEHS
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
CC, NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborn and Children
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2014
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
AIDSinfo/InfoSIDA
|
Public Education Campaign
|
CDC, FDA, HRSA
|
NIAID, NLM, OD/ DPCPSI/ OAR
|
2002
|
|
Alzheimer's Disease Neuroimaging Initiative (ADNI)
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
Unknown
|
|
American Academy of Pediatrics (AAP) Section on Obesity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
Unknown
|
|
American College of Obstetricians and Gynecologists (ACOG) Patient Education Review Panel
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
Unknown
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Artificial Intelligence Healthcare — From Prevention and Diagnostics to Treatments (aiPDT) - AI Workshop Science & Organization Committee
|
Meeting/ Workshop
|
FDA
|
NCI, NIBIB, NICHD, NLM, OD/ OIR
|
2019
|
|
Assay Guidance Workshop For High Throughput Screening And Lead Discovery
|
Meeting/ Workshop
|
FDA
|
NCATS, NCI, NIAAA, NIDDK
|
2015
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Bacteriophage Interest Group (Monthly Meeting)
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID
|
2016
|
|
Bacteriophage Therapy: Intraagency meeting
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2018
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NICHD
|
2009
|
|
Biodefense Coordination Team (BCT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
2019
|
|
Bioeconomy Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Biological Select Agents and Toxins Interagency Policy Committee (BSAT PPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
Unknown
|
|
Biological Select Agents and Toxins sub-Interagency Policy Committee (BSAT Sub-PPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
Unknown
|
|
Biomarkers Meeting
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID
|
2019
|
|
Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, NHLBI
|
2011
|
|
Blood, Organ, and Tissue Safety Committee (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
1997
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CC, NIAID
|
2012
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
|
Research Initiative
|
FDA
|
NCCIH, NEI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ OLPA, OD/ OSP
|
2000
|
|
Collaborative Use Repurposing Engine (CURE)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Combating Antibiotic Resistant Bateria (CARB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NIAID, NLM
|
2015
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
CounterACT Research Network Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NEI, NIAID, NICHD, NIEHS, NIGMS, NINDS, NLM
|
Unknown
|
|
Countering Biothreats PCC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-PCC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network
|
Research Initiative
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2006
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR
|
2007
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Demand Reduction Interagency Working Groups
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC
|
1990
|
|
Development and Use of a Non-human Primate Model of Pertussis Disease and Transmission
|
Other
|
FDA
|
NIAID
|
2011
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
CSR, NCATS, NCCIH, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
1974
|
|
Diagnostic Integrated Program Team (IPT) under Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2013
|
|
Diet-Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
NCI
|
2004
|
|
Dietary Supplements Clinical Research Roundtable
|
Meeting/ Workshop
|
FDA
|
NCCIH, NIEHS, OD/ DPCPSI/ ODS
|
2019
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Dominantly Inherited Alzheimer's Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer's Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Resource Development
|
FDA
|
NIDDK
|
2003
|
|
E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI): Developing a Research Agenda
|
Meeting/ Workshop
|
CDC, FDA
|
NCI, NHLBI, NIDA
|
2019
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
End-stage Renal Disease (ESRD) Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2003
|
|
Evaluation of Patient Reported Outcomes Following LASIK Surgery
|
Research Initiative
|
FDA
|
NEI
|
2009
|
|
Extracellular Ribonucleic Acid (RNA) Communication
|
Research Initiative
|
FDA
|
NCATS, OD/ DPCPSI/ OSC
|
2013
|
|
Extracting Adverse Reactions and Indexing the Content of Structured Product Labels (SPLs)
|
Resource Development
|
FDA
|
NLM
|
2016
|
|
Eye Research Collaboration
|
Other
|
FDA
|
NEI
|
2014
|
|
Fast Track Action Committee on Biosafety and Biosecurity (FTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2015
|
|
FDA Acute Radiation Syndrome (ARS) Action Team
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
2011
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
FDA Uterine Fibroids Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, OD/ DPCPSI/ ORWH
|
2017
|
|
FDA/NIH Interagency Clinical Outcomes Assessments Working Group Meeting
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NCI, NHLBI, NIAMS, NIMH, NINDS
|
2013
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OS
|
NHLBI, NIDDK, OD/ DPCPSI/ ODS
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal Health IT Coordinating Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM, OD/ OSP
|
2016
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Health Equity Team (FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NHLBI, NIA, NIAID, NICHD, NIMH, NIMHD
|
2006
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NICHD, NIEHS, OD/ DPCPSI/ ODP
|
Unknown
|
|
Federal RePORTER
|
Resource Development
|
ACF, ACL, AHRQ, CDC, FDA
|
OD/ OER
|
2008
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NEI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH
|
1993
|
|
FedTel: Cross-Federal work group on telehealth
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
FNIH Advanced Medicines Partnership on Gene Therapy
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
FNIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NINDS
|
2006
|
|
Foundation for the National Institutes of Health (FNIH) PACT (Partnership for Accelerating Cancer Therapies)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2017
|
|
Full-text health-related documents at NLM (includes HSTAT)
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, OSG, SAMHSA
|
NLM
|
1994
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ DPCPSI/ THRO, OD/ DPSCSI/ SGMRO, OD/ ECHO, OD/ IMOD, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ ORS, OD/ OSP
|
2016
|
|
Global Ingredient Archival System (GINAS)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Harmonization of various Common Data Models and Open Standards for Evidence Generation
|
Resource Development
|
FDA
|
NCATS, NCI, NLM
|
2016
|
|
HCS Research Collaboratory
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, OS
|
NCATS, NCCIH, NCI, NHLBI, NIA, NIAID, NIAMS, NIDA, NIDCR, NIDDK, NIMH, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ OSC
|
2012
|
|
Health and Social Services Recovery Support Function (H&SS RSF)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA
|
NIMH
|
2018
|
|
Healthy People 2020 - Kidney Disease
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2020 - Structured Evidence Queries (SEQs)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NLM
|
2009
|
|
Healthy People 2030 - Nutrition and Weight Status Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIDDK
|
2010
|
|
Healthy People Initiative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, OD/ DPCPSI/ ODP
|
1979
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
HHS Antimicrobial Resistance Challenge Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ DPCPSI, OD/ OSP
|
2015
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ ORS, OD/ OSP
|
2015
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NIA, NIAID, NICHD, NIDDK, NIMH, NIMHD
|
Unknown
|
|
HHS Data Council Data-Oriented Workforce Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA
|
NCATS, NLM, OD/ IMOD, OD/ OIR
|
2019
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
1990
|
|
HHS Global Health Collaborative
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
Unknown
|
|
HHS Health Disparities Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
2010
|
|
HHS HIV Bidirectional Meeting Planning Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIMH
|
2018
|
|
HHS Kidney Care Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
HHS LGBT Policies Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH, OD/ DPSCSI/ SGMRO
|
2011
|
|
HHS Open Innovation Community of Practice
|
Meeting/ Workshop
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NCI, NIDA, NIDDK, NIEHS, NLM
|
2018
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
Unknown
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
Unknown
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
Unknown
|
|
HHS Potential Pandemic Pathogens Care and Oversight Review Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2018
|
|
HHS Secretary's Initiative on Serious Mental Illness (SMI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
2015
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIAID
|
2017
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDA, NIDDK
|
2009
|
|
HHS-NASA Scientific Potential/Actual Collaborative Efforts (SPACE) group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA
|
FIC, NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, OD/ IMOD
|
2019
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
CC, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, OD/ OIR
|
1990
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Other
|
FDA
|
NIAID
|
2019
|
|
Inclusion Across the Lifespan
|
Meeting/ Workshop
|
FDA
|
NCI, NHLBI, NIA, NICHD, NIDCR, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ OER
|
2016
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Interagency Agreement with the Food and Drug Administration (FDA)
|
Other
|
FDA
|
NIAID
|
2016
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NICHD, NIDCD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Biodefense Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
FIC, NIAID, NIEHS, NLM, OD/ OM/ OB, OD/ ORS, OD/ OSP
|
2018
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
BARDA, CDC, FDA
|
OD/ OER
|
2016
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
1985
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
CSR, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR
|
2003
|
|
Interagency Oncology Task Force Fellowship: Track 4
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Serological Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD, NIMH
|
2018
|
|
Interagency Workgroup on Coordinating Opportunities for Evaluating Dolutegravir and Neural Tube Defects Association
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2018
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Interagency Working Group in the Glycosciences
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Interagency working group on Biological Data Sharing
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIGMS
|
2018
|
|
Interdepartmental Health Equity Collaborative (formerly FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
Interferon Lambda (IFN-?): Disease Impact and Therapeutic Potential
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID, NIDDK
|
2017
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders' Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NEI, NHGRI, NIAMS, NICHD, NINDS
|
2011
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID, OD/ OSP
|
2005
|
|
Joint Agency Nutrition (JAN) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS
|
2016
|
|
Joint External Evaluation Working Group (JEEWG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIEHS, NINDS, OD/ ORS, OD/ OSP
|
Unknown
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Kidney, Urologic, & Hematologic Diseases Interagency Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCCIH, NCI, NHLBI, NIA, NICHD, NIDDK, NINDS
|
1987
|
|
KidneyX (Kidney Innovation Accelerator)
|
Research Initiative
|
CMS, FDA
|
NIDDK
|
2018
|
|
LGBT Healthy People 2030 Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, OD/ DPCPSI/ ODP, OD/ DPSCSI/ SGMRO
|
2019
|
|
Library of Integrated Network-based Cellular Signatures (LINCS)
|
Research Initiative
|
FDA
|
NHGRI, NHLBI, OD/ DPCPSI/ OSC
|
2016
|
|
Lower Limb Prosthetics Research Standards Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CMS, FDA
|
NICHD, NIDDK
|
Unknown
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCIH, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2003
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Materials Genome Initiative
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB
|
2018
|
|
Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NICHD, NIMHD, OD/ DPCPSI/ ORWH
|
2019
|
|
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2015
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Drug Evaluation and Research (FDA/CDER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2019
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC
|
2012
|
|
Monthly Zika Vaccine Development Meeting
|
Resource Development
|
BARDA, FDA
|
NIAID
|
2018
|
|
Multinational Influenza Seasonal Mortality Study (MISMS) Research
|
Research Initiative
|
FDA, OS
|
FIC, NHLBI, NIAID, NLM
|
2001
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
NATIONAL ACTION PLAN FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Center for Advancing Translational Sciences (NCATS) Patient-focused Therapeutics Development Toolkit
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Care Commission
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
2018
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Emerging Technologies Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2005
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCI, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Institutes of Health (NIH) Metabolomics Scientific Interest Group
|
Other
|
FDA
|
NCI, NHLBI, NIA, NIAAA, NIAID, NIDCR, NIDDK, NIEHS, NIMH, NLM, OD/ DPCPSI/ ODS
|
2007
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program (NKDEP)
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
2000
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
Natural History of Ebola Virus Zaire (Kikwit-7U) in Cynomolgus Macaques
|
Resource Development
|
FDA
|
NIAID
|
2018
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI Convenes Workshop on Reproducibility of Fecal Microbiota Transplants in Cancer Therapeutics
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID
|
2019
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
NCI
|
2015
|
|
NCI/FDA Memorandum of Understanding for Drug Related Information
|
Resource Development
|
FDA
|
CC, NCI, NHGRI, NHLBI, NIAID, NIDCR, NLM
|
2012
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
NCI/FDA/HRSA/CMS Task Force on Cancer Diagnostic Devices (CD2) for Near-Patient Use
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
NCI
|
2019
|
|
New Molecular Methods for Evaluation of Antibody Responses Following RSV Vaccination and Infection
|
Other
|
FDA
|
NIAID
|
2017
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, FDA, HRSA, OS
|
NHGRI, NHLBI, NICHD, NLM
|
2007
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHLBI, NICHD, NLM
|
2009
|
|
NIAID/FDA/BARDA Meeting on Cutaneous Radiation Injuries
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID
|
2018
|
|
NIAID/FDA/BARDA Meeting on Radiation-Induced Lung Injuries
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID
|
2018
|
|
NIAID/NASA Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NHLBI, NIAID
|
2017
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH-FDA Biomarkers Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2008
|
|
NIH-FDA Interagency Clinical Outcome Assessments (ICOA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCCIH, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
NIH-FDA Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCCIH, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS, OD/ OSP
|
2010
|
|
NIH-FDA Medical Device Research Interest Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIBIB, NICHD, NIDDK, NINR, OD/ DPCPSI/ ORIP
|
2016
|
|
NIH/BMGF Collaboration - Point of Care Testing Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI, NIAID, NIBIB, NICHD
|
2016
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
Unknown
|
|
Nutrition Research Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, IHS, OS
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ODS
|
1975
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, OSG
|
NCI, NIBIB
|
2011
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Pediatric Device Consortia Grants Program
|
Research Initiative
|
FDA
|
NICHD
|
2009
|
|
PFI Biopharmaceutical Classification System (BCS) Task Specific Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NLM
|
2005
|
|
Policies and Regulatory Pathways to FDA Licensure
|
Other
|
FDA
|
NIAID
|
2018
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Pregnancy and Birth to 24 Months (P/B-24) Project's Federal Expert Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
President’s Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS, OD/ DPCPSI/ ODP
|
Unknown
|
|
Probiotic and Prebiotic Working Group [PPWG]
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NCI, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS
|
2006
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Pediatrics and Obstetrics Integrated Program Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD, NIGMS
|
2006
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Quantitative Data Mining for Drug-Adverse Event Safety Signal Detection Using MEDLINE
|
Research Initiative
|
FDA
|
NLM
|
2012
|
|
Quantum Barcoding for analysis of Ebola infection
|
Other
|
FDA
|
NIAID
|
2019
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Meeting/ Workshop
|
FDA, OS
|
NCI, NIAID
|
2003
|
|
RADx Tech Program
|
Research Initiative
|
BARDA, FDA
|
NIBIB
|
2019
|
|
Rare Disease Day
|
Meeting/ Workshop
|
FDA
|
NCATS, NHLBI
|
2017
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
2007
|
|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
2018
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
2018
|
|
Repurposing Off-Patent Drugs: Research & Regulatory Challenges
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2019
|
|
Review of Applications for the Biomedical Data Translator: Development Phase
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NHGRI, NIDDK, NLM
|
2019
|
|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
2009
|
|
Seasonal Influenza Vaccine Improvement Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2010
|
|
Smokefree.gov
|
Resource Development
|
CDC, FDA, IHS
|
NCI, NIMHD, OD/ DPCPSI/ OBSSR
|
2003
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ OSC
|
2017
|
|
Specificity and Quality of Influenza-Specific Antibodies
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Steering Committee of the Scientific Interest Group in Glycobiology
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Stimulating Peripheral Activity to Relieve Conditions
|
Research Initiative
|
FDA
|
NCATS, NCCIH, NCI, NEI, NHLBI, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIMH, NINDS, OD/ DPCPSI/ OSC
|
2016
|
|
Structured Data Capture (SDC) Initiative
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCATS, NCI, NLM
|
2013
|
|
Subcommittee on Open Science
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, OS
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, OS
|
NLM
|
2013
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM
|
2003
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA
|
NIAID
|
2014
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, SAMHSA
|
NCATS, NHLBI, NIAID, NICHD, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2017
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCATS, NCCIH, NHLBI, NIAID, NICHD, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2017
|
|
The Effect of Various Drugs on the Retina
|
Research Initiative
|
FDA
|
NEI
|
2014
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIDDK
|
2013
|
|
The wireless sensing and artificial intelligence (AI) for smart healthcare Work Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIBIB
|
2018
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2009
|
|
Tissue Chip Testing Centers
|
Research Initiative
|
FDA
|
NCATS
|
2016
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
FIC, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NLM, OD/ DPCPSI/ ODP
|
2003
|
|
Tobacco Centers of Regulatory Science (TCORS)
|
Research Initiative
|
FDA
|
OD/ DPCPSI/ ODP
|
2013
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
NCI
|
2016
|
|
Tobacco Products Scientific Advisory Committee (TPSAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
OD/ DPCPSI/ ODP
|
2010
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Tobacco Use Supplement to Current Population Survey
|
Health Survey
|
CDC, FDA
|
NCI, NIMHD
|
1992
|
|
Tox 21
|
Resource Development
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2009
|
|
Trans-NIH Working Group for Objective Measures in Cancer
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB, NIDDK
|
2017
|
|
Transformation of PROWL Survey into Electronic Form.
|
Health Survey
|
FDA
|
NEI, NLM
|
2016
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NIAID
|
2013
|
|
U.S. FDA Medical Imaging Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC
|
2015
|
|
Understanding and Identifying the Needs for Medical Devices
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2014
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
1990
|
|
United States Government Children in Adversity Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA
|
FIC, NICHD, NIEHS, NIMH
|
2011
|
|
United States Government Global Nutrition Coordination Plan
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2016
|
|
Urine biomarkers and risk of lung cancer in the Sisters Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
2019
|
|
US Agency for International Development Antiretroviral Optimization Program Advisory Committee (USAID ART Optimization PAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
US Government Inter agency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIEHS
|
2005
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAID
|
2015
|
|
USDA-HHS Birth to 24 Months & Pregnant Women Project Federal Expert Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2012
|
|
Vaccine Research Center (VRC) - National Vaccine Program Office (NVPO) Collaboration
|
Other
|
CDC, FDA
|
NIAID
|
2018
|
|
Vaccine Working Group (Filovirus)
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NIAID
|
2018
|
|
Virology Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
1994
|
|
Workshop on Metabolic Interactions between Folic Acid Excess and Vitamin B12 Deficiency
|
Meeting/ Workshop
|
FDA
|
NCI, NIA, NICHD, NIDDK, OD/ DPCPSI/ ODS
|
2019
|
|
Zika Supplement for Virus Tissue Tropism During Pregnancy
|
Resource Development
|
FDA, HRSA
|
NIAID
|
2016
|
|
|